KRT1 and thyroid cancer: Interestingly, K1 and BCPAP cells co-treated with Acrp30 and leptin displayed the same invasion capability of untreated cells indicating that Acrp30 and leptin display antagonizing effects on thyroid cancer cell invasion (Fig. 7).